- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-6551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Quantification of 11C-PIB kinetics in cardiac amyloidosis ; day:23 ; month:7 ; year:2018 ; pages:1-11
Journal of nuclear cardiology ; (23.7.2018), 1-11
- Creator
-
Kero, Tanja
- Contributor
-
Sörensen, Jens
Antoni, Gunnar
Wilking, Helena
Carlson, Kristina
Vedin, Ola
Rosengren, Sara
Wikström, Gerhard
Lubberink, Mark
SpringerLink (Online service)
- DOI
-
10.1007/s12350-018-1349-x
- URN
-
urn:nbn:de:101:1-2018092600313664024065
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kero, Tanja
- Sörensen, Jens
- Antoni, Gunnar
- Wilking, Helena
- Carlson, Kristina
- Vedin, Ola
- Rosengren, Sara
- Wikström, Gerhard
- Lubberink, Mark
- SpringerLink (Online service)
Other Objects (12)
![[11C]PIB amyloid quantification: effect of reference region selection](/assets/placeholder/searchResultMediaUnknown.png)
[11C]PIB amyloid quantification: effect of reference region selection
Quantification and accuracy of clinical [11C]-PiB PET/MRI: the effect of MR-based attenuation correction
Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reduction
Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [11C]PiB
Estimation of brain amyloid accumulation using deep learning in clinical [11C]PiB PET imaging
PiB
Quantification of [11C]PBR28 data after systemic lipopolysaccharide challenge
Pharmacokinetic modeling of [11C]flumazenil kinetics in the rat brain
Global quantification of cellular protein degradation kinetics
Decreased Gray—White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea
Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [11C]PiB amyloid imaging
[11C]PIB amyloid quantification: effect of reference region selection
Quantification and accuracy of clinical [11C]-PiB PET/MRI: the effect of MR-based attenuation correction
Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reduction
Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [11C]PiB
Estimation of brain amyloid accumulation using deep learning in clinical [11C]PiB PET imaging
PiB
Quantification of [11C]PBR28 data after systemic lipopolysaccharide challenge
Pharmacokinetic modeling of [11C]flumazenil kinetics in the rat brain
Global quantification of cellular protein degradation kinetics
Decreased Gray—White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea
Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [11C]PiB amyloid imaging
[11C]PIB amyloid quantification: effect of reference region selection
Quantification and accuracy of clinical [11C]-PiB PET/MRI: the effect of MR-based attenuation correction
Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reduction
Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [11C]PiB
Estimation of brain amyloid accumulation using deep learning in clinical [11C]PiB PET imaging
PiB
Quantification of [11C]PBR28 data after systemic lipopolysaccharide challenge
Pharmacokinetic modeling of [11C]flumazenil kinetics in the rat brain
Global quantification of cellular protein degradation kinetics
Decreased Gray—White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea
Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?